论文信息 - The impact of increased utilization of HIV drugs on longevity and medical expenditure: an assessment based on aggregate US time-series data

The impact of increased utilization of HIV drugs on longevity and medical expenditure: an assessment based on aggregate US time-series data

The objective of this Special Report is to estimate the medical cost per life-year gained from increased utilization of HIV drugs by estimating the impact of increased drug utilization on the life expectancy and drug and hospital expenditure of HIV/AIDS patients, using aggregate (US national-level) data for the period 1982–2001.

F. Lichtenberg

[1] R. Hardy,et al. Measuring the impact of HIV/AIDS, heart disease and malignant neoplasms on life expectancy in the USA from 1987 to 2000. , 2006, Public health.

[2] M C Weinstein,et al. The cost effectiveness of combination antiretroviral therapy for HIV disease. , 2001, The New England journal of medicine.

[3] Kevin M. Murphy,et al. The Economic Value of Medical Research , 2000 .